Abstract -Several examples will be described which illustrate recent researches in Cambridge on the biosynthesis of vitamin BI2. A brief historical survey to provide the background for the latest work will be followed. by the results of synthetic an6 labelling experiments on the structure and oxidation level of the first methylation product (precorrin-I) on the pathway. The problem of when the 12-acetate residue undergoes decarboxylation will be discussed together with experiments on pyrrocorphins, the latter being putative intermediates on the biosynthetic pathway. The final part of the lecture will focus on the chemistry of hydroxymethylbilane synthase, the enzyme responsible for assembly of four monopyrrolic building blocks into an open chain system which is an early precursor of the macrocycle of vitamin B12. The mechanism of action of this enzyme has heen proved to involve a novel cofactor which has a pyrromethane structure.
INTRODUCTION
The full account of all the B,2 biosynthetic work to be described would require much more space than is available in this "long abstract". I shall therefore use flow schemes of structures which are connected by a highly condensed narrative. The first 10 years of work (before E.
1978) by all groups in this area has to be cited previous reviews but full details of more recent studies can be found in the papers in the reference list.
The structure of vitamin B 1 2 is shown in Scheme 1 and it was known (ref. 1 ) before the outset of our work that the vitamin is formed from cobyrinic acid, which acts as a late precursor, Scheme 1.
So the problem of discovering how the macrocycle of vitamin B12 is biosynthesised resolves itself into that of how cobyrinic acid is constructed. Knowing (ref. 1) 
T I M I N G OF DECARBOXYLATION OF THE 12-ACETATE GROUP
It was known (ref. 10) that the crude enzyme preparation from Propionibacterium shermanii would accept, rather than its normal substrate uro'gen-I11 with R=CH2C02H, also the synthetic 12-methyl analogue with R=Me, Scheme 7. By using purified enzymes, it was possible also to carry out the next 2-methylation at C-20 of the analogue with R=Me, Scheme 8. In this way, the analogue of precorrin-3 having R=Me, Scheme 8, was prepared in I4C-labelled form and isolzted as the aromatised isobacteriochlorin system (ref. 11).
Comparison was made of the incorporation of precorrin-3' relative to that of its 12-decarboxylated analogue (Scheme 8, R=Me) using the enzyme system which biosynthesises cobyrinic acid. Precorrin-3 was incorporated well into cobyrinic acid (up to 10%) whereas the 12-decarboxylated analogue did not act as a significant precursor (incorporation 0.025%), (ref. 11).
(Scheme 8, R=CH CO H) For reasons to be discussed in the lecture, these results indicate that: (a) precorrin-3 does not undergo decarboxylation of its 12-acetate group (b) the 12-methyl analogue of precorrin-3 is not a biosynthetic intermediate and (c) two pyrrocorphins are likely to exist with, respectively, R=CH C02H and R=Me at the 12-posi tion since for mechanistic reasons, the 12-acetgte residue is probably decarboxylateJ ber'ore the 12-R-methyl group oE cobyrinic acid is introduced (see structure of cobyrinic acid, Scheme 1).
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SYNTHESIS OF PYRROCORPHINS W I T H ESTER SIDE CHAINS
Scheme 9 shows one example of the outstanding work of Eschenmoser -a1 (3. ref. 12) in which a dihydroisobacteriochlorin was isomerised and C-methylated with a preference for C-17. It may thus be possible to prepare the ester of the pyrrocorphin in Scheme 6 from precorrin-3 ester, see Scheme 10. There are two major problems (a) the conditions using a Grignard reagent in Scheme 9 cannot be used in the presence of esters and (b) precorrin-3 ester is chiral and so stereochemical problems are superimposed on control of regio-chemistry; 16 isomers can arise.
Conditions were eventually found to allow pyrrocorphins with ester side chains to be prepared, Scheme 1 1 ; the isomers were separate6 and their structures determined (ref. 13). Excitingly, precorrin-3 has been converted into a mixture of pyrrocorphinates, Scheme 12, ready for C-methylation and subsequent incorporation experiments with labelled materials (ref.
.-,, 3C-spectrum of unlabelled enzyme-'C-PBG, mono-complex. The difference between these two spectra, showed 1 -I 3 CH group attached exacgly to a one s t r k g signal at 624.6 from the I3C-enriched to the ):-group, Figure 2 ; the shift corresponded pyrrole-' 3CH2-pyrrole system (ref. 1 6 ) .
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Thus, the P3G unit added first binds to a tightlv bound pyrrole residue already present in the enzyme. Turnover of 12 mol "C-PBG per mol HMBS followed by reisolation of the holoenzyme gave unlabelled enzyme still carrying the tightly bound pyrrolic system. Hence the latter is present as a cofactor in the enzyme in addition to the PBG units which are turned over (ref. 16 ).
The nat.&ire of the tightly bound pyrrolic system was studied by treating ZMBS with acidic p -d i m e t h y l a m i n o b e n z a l d e h y d e (Ehrlich's reagent). This caiined striking spectroscopic changes shown by studies with synthetic mo:?.el. systems, to be characteristic of a pyrromethane group. The pyrromethane cnfac.tor is hound to the protein through a group Y, Scheme 15. Cleavage of the pyrromethane from the Y-group by acid caused l o s s of enzymic ac.tivity and the pyrromethane fragment reacted with another molecule of the same fragment to generate mainly uroporphyrinogen-I, uro'gen-I, which is isomeric with uro'gen-I11 (Scheme 13) but has the A & P groups running in sequence around the periphery of the macrocycle. It is the formation of this product which leads to knowledge of the acidic side-chains of the pyrromethane cofactor.
The above enzymically inactive protein lacking the pyrromethane cofactor (apoenzyme) can be restored to active enzyme by incubation with PBG (ref. 17) . was regenerated with a I3C-atom directly connected to the Y-group. 13CN.m.r. difference spectroscopy, as for the X-group experiments, then revealed that Y is sulphur. Thus, the pyrromethane cofactor is attached to the protein the sulphur atom of a cysteine residue (ref. 17).
It was also important to generate labelled XMBS in a natural way by growing the E. coli which produces the enzyme in the presence of 13C-labelled aminol~.evulinc acid, the precursor of PBG. The labelled precursor was incorporated well into HMBS to generate the labelling pattern shown in Scheme 16. 13C-N.m. r. difference spectroscopy conf irmec! unambiguously By using 11-I3C-PBG (Scheme 15) in this incubation, HMBS that Y is sulphur (ref. 18) and showed signals of the correct chemical shift for the other three I3C-labels in that cofactor, Scheme 16 (ref. 18).
All these results interlock to prove that the assembly process on HMBS involves construction of a hexapyrrole from which the hydroxymethylbilane is cleaved, Scheme 17. The bound pyrrcmethane of HMBS represents a unique enzymic cofactor which the apoenzyme can self-assemble from PBG onto a cysteine residue; this cofactor is essential for the catalytic process (biit is not turned over) yet is built from the substrate for that enzyme.
As shown in Scheme 17, the hydroxymethylbilane is ring-closed with rearrangement to form uro'gen-111. There is strong evidence from synthetic studies (ref. 19 ) that the dashed pathway in Scheme 13 via the spirosystem is used to achieve this formation of uro'gen-111- Though work on the unknown part of the B biosynthetic pathway is now evperimentally very demanding, futiire st?iies will surely lead to a full understanding of how this marvellous molecule is built in Nature. 
